Poster Presentation 18th International Symposium on Dendritic Cells 2026

Type 2 conventional dendritic cells limit responsiveness to cancer immunotherapy (#241)

Nayvin W Chew 1 2 , Shayan C. Avanessian 2 3 , Renske J.E. van den Bijgaart 2 , Yogesh Kushwaha 2 , Thao T. Tang 2 , Tomas Bencomo 4 , Carolyn Shasha 5 , Lauren E. Martin 6 , Kokoro Abe 7 , Jordan Gauthier 7 8 , Aude G. Chapuis 6 , Paul Nghiem 4 , Anthony Rongvaux 6 , Evan Newell 5 , Kevin C. Barry 1 2 3
  1. Department of Immunology, University of Washington, Seattle, WA, 98109, United States
  2. Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States
  3. Program in Molecular and Cellular Biology, University of Washington, Seattle, WA, 98195, United States
  4. Department of Dermatology, University of Washington, Seattle, WA, 98195, United States
  5. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States
  6. Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States
  7. Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, United States
  8. Department of Medicine, University of Washington, Seattle, WA, 98195, United States
Publish consent withheld